Slide1 l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 33

Neurodevelopmental Assessment and Care of Premature Infants Ma. Teresa C. Ambat, MD Neonatology-TTUHHSC 10/28/2008 PowerPoint PPT Presentation

  • Uploaded on
  • Presentation posted in: General

Neurodevelopmental Assessment and Care of Premature Infants Ma. Teresa C. Ambat, MD Neonatology-TTUHHSC 10/28/2008. Introduction. PCPs should be vigilant in following outcomes of prematurely born child

Download Presentation

Neurodevelopmental Assessment and Care of Premature Infants Ma. Teresa C. Ambat, MD Neonatology-TTUHHSC 10/28/2008

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript

Slide1 l.jpg

Neurodevelopmental Assessment and Care of Premature Infants

Ma. Teresa C. Ambat, MD



Introduction l.jpg


  • PCPs should be vigilant in following outcomes of prematurely born child

  • Should integrate and adapt assessments of development, neurologic status and bahavior for each child at each encounter

Neurodevelopmental and behavioral outcomes l.jpg

Neurodevelopmental and Behavioral Outcomes

  • Long-term outcome arises from complex interplay of biologic, genetic, social and environmental factors

  • Additional or shifting developmental dysfunction over time, as more subtle disabilities become increasingly apparent and testable “new morbidities”

Risk factors for developmetal and behavioral problems in the preterm infant l.jpg



GA <28 wks


Male gender


Neonatal seizures

Abnormal HUS (white matter injury,

PVL, Grade 3-4 IVH)

CLD Prolonged mechanical vent

Infections (NEC, sepsis, meningitis)

Feeding problems >34 wks PMA


Low economic status

Maternal depression

Risk Factors for Developmetal and Behavioral Problems in the Preterm Infant

Prevalence of significant disabilities in vlbw l.jpg

Prevalence of Significant Disabilities in VLBW

Correction for prematurity l.jpg

Correction for Prematurity

  • Correction for prematurity up to 2-3 years of age when considering neurologic, developemental or behavioral issues, otherwise indicated by a standardized evaluation

Pearls on outcomes of preterm infants l.jpg

Pearls on Outcomes of Preterm Infants

  • More frequent and significant disabilities are associated with decreasing GA and BW

  • Cognitive deficits > motor deficits

  • Disabilities or delays may be subtle or appear latently

  • Deficits in cognitive, verbal, perceptual, motor and visuo-motor measures may not manifest until school age

Pearls on outcomes of preterm infants8 l.jpg

Pearls on Outcomes of Preterm Infants

  • Up to 50% of infants born <25 wks may be found without disability at follow up over the 1st 3 yrs

  • Nearly all infants with normal findings on neurodevelopmental examination at the infant’s expected due date continue to develop normally

  • If no developmental delays during infancy, risk of MR or CP is low

Ophthalmologic issues l.jpg

Ophthalmologic Issues

  • Ophthalmologic problems of premature infants

    • ROP, strabismus, myopia – common

    • Higher incidence of visual impairment – 45-60%

    • Poor visual function may directly affect the development of motor and cognitive skills

  • Require specialized ophthalmologic testing and routine follow-up by pediatric ophthalmologist

Rop screening l.jpg

ROP Screening

  • AAP recommendation for ROP screening

    • Indications

      • GA <30 wks or BW <1500g

      • Selected infants with BW 1500 – 2000g, GA >30 wks with severe cardiorespiratory instability

    • Examinations usually begin at 4-6wks postnatal age or at 31-32 wks postmenstrual age

    • Continue every 2 wks

    • Once ROP is noted at any stage, examinations become more frequent

    • Can be discontinued once the retinal vessels have reached the perimeter of Zone 3 – retina is “mature”

Outpatient monitoring for infants at risk for rop l.jpg

Outpatient Monitoring for Infants at Risk for ROP

  • Confirm that retinal maturation is complete

    • If mature, arrange for ophthalmologic ff up at 6-9 months to monitor for amblyopia, strabismus and or refractive errors

    • If immature, ophthalmologic ff-up per previous guidelines

  • All PT <32 wks, should undergo ophthalmologic screening at 6-9 months chronologoic age,

    • Whether or not they were screened for ROP, developed ROP or received tx for ROP

  • All PT should have formal visual acuity screening, at least once during preschool years

  • If visual difficulties are seen, refer to appropriate resources

Hearing loss in premature infants l.jpg

Hearing Loss in Premature Infants

  • Overall incidence of severe congenital hearing loss:

    1-3/1000 live births

  • Hearing loss in premature infants: 2-4/100 infants born <32 wks

Risk factors for hearing loss joint committee on infant hearing l.jpg

Risk Factors for Hearing Loss(Joint Committee on Infant Hearing)

  • Parental or caregiver concern re: hearing, speech, language or developmental delay

  • Family history of permanent childhood hearing loss

  • Stigmata associated with a syndrome known to cause hearing loss or eustachian tube dysfunction

  • Postnatal infection associated with SNHL – bacterial meningitis

  • Congenital infections – CMV, HSV, rubella, syphilis, HIV, toxoplasmosis

  • Syndromes associated with progressive hearing loss – NF, osteopetrosis, Usher syndrome

Risk factors for hearing loss joint committee on infant hearing14 l.jpg

Risk Factors for Hearing Loss(Joint Committee on Infant Hearing)

  • Neonatal indicators – hyperbilirubinemia requiring exchange (TB >20, needs BAER at 2months), PPHN associated with mechanical ventilation or ECMO

  • Nuerodegenerative disorders – Hunter syndrome, Friedrich ataxia, Charcot-Marie Tooth

  • Head trauma

  • Recurrent or persistent OM with effusion for at least 3 months

  • Prolonged use of potentially ototoxic drugs

Screening tests l.jpg

Screening Tests

  • Universal hearing screening recommended for all newborns

  • Methodologies for physiologic screening for hearing in newborns

    • Auditory brainstem response (ABR)

    • Evoked otoacoustic emission (EOAE)

Follow up testing and medical evaluation l.jpg

Follow-up Testing and Medical Evaluation

  • Infants who refer in both ears  diagnostic ABR within 2 wks

  • Unilateral abnormal results  ff-up testing within 3 months

  • Ff-up testing: full diagnostic frequency ABR to measure threshold, evaluation of middle ear function, observation of behavioral response to sound, parental report of emerging communication and auditory behaviors

Follow up testing and medical evaluation17 l.jpg

Follow-up Testing and Medical Evaluation

  • Any infants at risk for progressive or delayed hearing loss  close audiologic monitoring at least q6 months for the first 3 years)

  • Hearing assessment at 1 year in all infants born at < 32 wks (even if hearing screen is passed)

  • PCP should monitor all infants for normal hearing and language development and refer any infant with delays for hearing assessment

Referrals l.jpg


  • Once an infant is diagnosed with a true hearing loss, the following referrals should be made:

  • Complete evaluation by an otolaryngology or otology specialist who has experience with infants

  • Genetic evaluation and counseling (hearing loss with no definite etiology)

  • Pediatric ophthalmology (evaluate for additional sensory loss)

  • Developmental pediatric, neurology, cardiology, and or nephrology as indicated by other clinical findings and known associated problems with syndromes

Habilitation management l.jpg


  • Early intervention services to enhance acquisition of developmentally appropriate language skills

  • Amplification systems – hearing aids

  • Cochlear implant: profound, bilateral SNHL, no benefit from hearing aids, no medical conditions that will interfere with procedure, realistic expectations from family

  • “Stimulation” or “mapping” sessions

White matter injury l.jpg

White Matter Injury

  • Periventricular leukomalacia (PVL) – white matter injury in preterm infants

  • Results from insults to the developing brain 23-32 wks

  • Incidence: 5-15% of those born GA<32 wks

  • US: echodensity in periventricular white matter adjacent to lateral ventricles  cystic changes

  • Outcomes: MR, CP, developmental delay, visual impairments

Intraventricular hemorrhage l.jpg

Intraventricular Hemorrhage

  • Occurs in ~35-50% of infants born <35 wks

  • Grade III IVH associated with 30% risk of CP/MR and 50% risk of developmental disability

  • Intraparenchymal hemorrhage associated with 70% risk of CP/MR and 90% risk for developmental disability

Care and assessment of shunted neonates l.jpg

Care and Assessment of Shunted Neonates

  • Closely observe for long-term complications

  • Over-drainage related problems

    •  collapse of thin cortex, subdural effusion/hematoma, craniosynostosis

    • Evidenced by sunken fontanel, overlapping sutures

    • MX: positional precautions, upgrade or readjustment of valve settings

  • Wound breakdown

  • Shunted infants with myelomeningocele

    • Arnold-Chiari II malformation

    • Risk for brainstem dysfunction secondary to compression (retropulsion of head, stridor, drooling, increased tone in extremities)

Neurologic surveillance l.jpg

Neurologic Surveillance

  • Perform periodic neurologic examinations

  • Tone (passive resistance)

  • Strength (active resistance)

  • DTR

  • Coordination, station and gait

  • Use assessments over time to establish prognosis

  • Single encounters provide a mere snapshot of ongoing developmental trajectories

Neurologic surveillance26 l.jpg

Neurologic Surveillance

  • Abnormal tone can be suggestive of CP or

  • Maybe transient  resolve in the 1st year w/o sequelae

  • May evolve from one form to another (hypotonia  hypertonia)

  • Multidisciplinary evaluation

  • Extensive evaluations as necessary: MRI, cytogenetic studies, metabolic work-up

Findings of abnormal tone l.jpg


Exaggerated head lag

Excessive ‘slip through’ when held at the shoulders

Poor head control

Poor truncal tone  exaggerated curve in ventral suspension

Persistent hypotonia + decreased DTRs


Spastic form

Dyskinetic form with rigid extension

Early rolling over

Hypertonia with leg extension

Absent weight bearing

Persistent/early feeding problems

Findings of Abnormal Tone

Neurologic surveillance28 l.jpg

Neurologic Surveillance

  • Assess for persistence or delay of reflexes

  • Primitive reflexes

    • Moro, tonic labyrynthe, asymmetric tonic neck

    • Appear and readily elicited in the 1st 3 months  disappear by 6-8 months

  • Postural reflexes

    • Complex, self-protective reflexes involving righting, protection and equilibrium movements

    • Slow to evolve in children with CNS injury

Developmental surveillance l.jpg

Developmental Surveillance

  • Assess neurodevelopmental and behavioral status

    • Developmental tools – screening tools, not diagnostic tools

    • Parent questionnaires, history and discussion during clinical encounter

  • Consult appropriate specialists if results are concerning

Aap algorithm for developmental surveillance and screening pediatrics vol 118 july 2006 l.jpg

AAP Algorithm for Developmental Surveillance and ScreeningPediatrics Vol 118, July 2006

  • Developmental surveillance incorporated at every well-child visit

  • If any concerns  standardized developmental screening tests

  • Regular screening tests: 9, 18 and 30 (24) month visits

  • Children diagnosed with developmental disorders: children with special health care needs requiring chronic condition management

Developmental surveillance32 l.jpg

Developmental Surveillance

  • Login